Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis
Author(s) -
Hervé Dupont,
Laurent Massias,
Boris Jung,
Nacim Ammenouche,
Philippe Montravers
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw568
Subject(s) - anidulafungin , medicine , cmin , pharmacokinetics , candida parapsilosis , cmax , fluconazole , candida tropicalis , fungemia , candida glabrata , population , gastroenterology , surgery , mycosis , antifungal , micafungin , environmental health , dermatology
Only limited pharmacokinetic data are available for anidulafungin in ICU patients, especially in patients treated for severe intra-abdominal infection (IAI).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom